FDA Approves One-Day Treatment for Herpes

New dosing regimens can prevent or supress herpes outbreaks as they occur.

There is good news ahead for herpes patients, who usually suffer through a week of treatment before their pain and symptoms are resolved.

The FDA has recently approved Famvir as a one-day treatment option for patients with genital herpes, the first of its kind. Used properly, under the new FDA dosing regimen guidelines, Famvir can be used to prevent herpes outbreaks or curtail them as they occur.

This is a huge step in treatment for a virus that affects 45 million people in the U.S. and whose symptoms often go undetected.

The key to herpes treatment is managing the virus in the first signs of an outbreak, when the virus is most active. Studies showed that patients who were treated with Famvir at these critical moments greatly shortened the period of time needed for recovery from herpes symptoms.

A 1,500-milligram once-a-day dosage has been approved for cold sores, to be taken for one day at the onset of an outbreak.

A 1,000-milligram twice-a-day for one day dosage has been approved for genital herpes patients, to be taken for one day as symptoms occur.

Genital herpes is a sexually transmitted disease caused by the herpes simplex viruses (HSV) type 1 and type 2. Most genital herpes is caused by HSV type 2.

While there is no cure for herpes, the new dosage of Famvir approved by the FDA can help treat its symptoms with greater ease and efficiency.